- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03788096
Peer Support for Post Intensive Care Syndrome Self-Management (PS-PICS)
Peer Support for Post Intensive Care Syndrome Self-Management (PS-PICS)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Temple, Texas, United States, 76508
- Recruiting
- Baylor Scott & White Health
-
Contact:
- Richard Hao
- Phone Number: 214-265-3683
- Email: Richard.Hao@BSWHealth.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age18 years or older
- ICU length of stay 8 days or longer
- expected to survive hospitalization with a discharge destination to home within 28 days of hospital discharge
- diagnosed with 2 or more chronic conditions.
Exclusion Criteria:
- death prior to hospital discharge
- enrollment in Hospice services at the time of hospital discharge
- non-communicative
- no access to telephone
- incarcerated
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: PS-PICS Peer Support Intervention
ICU mentors will be responsible for providing support to survivor participants randomized to the PS-PICS peer support intervention.
Mentors will be trained in motivational interviewing techniques to engage mentees in goal setting and emotional management that is not readily accessible as part of discharge planning.
|
Mentors will trained in motivational interviewing and will conduct weekly telephone calls with participants randomized to the PS-PICS peer support intervention arm.
|
Placebo Comparator: Usual Care Group
A control intervention will be used to provide comparison data consistent with usual care (absence of structured peer support telephone intervention) to evaluate the impact of the PS-PICS peer support intervention.
|
Usual care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Social Network Index
Time Frame: 3 months post-intervention
|
Social Network Index (SNI) to measure social relationships.
The scale range is 0-12.
The total score will be reported.
The maximum total score is 12. Higher values represent a broader diversity of social networks and are classified as a better outcome.
|
3 months post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Center for Epidemiologic Studies Depression Scale (CES-D)
Time Frame: 1-week Post-intervention
|
Center for Epidemiologic Studies Depression Scale (CES-D) to measure self-reported symptoms of depression The scale range is 0-60.
The total score will be reported.
The maximum total score is 60.
Higher values represent self-reported symptoms of depression.
Higher values represent a worse outcome.
|
1-week Post-intervention
|
Center for Epidemiologic Studies Depression Scale (CES-D)
Time Frame: 3 months post-intervention
|
Center for Epidemiologic Studies Depression Scale (CES-D) to measure self-reported symptoms of depression The scale range is 0-60.
The total score will be reported.
The maximum total score is 60.
Higher values represent self-reported symptoms of depression.
Higher values represent a worse outcome.
|
3 months post-intervention
|
Social Network Index
Time Frame: 1-week Post-intervention
|
Social Network Index (SNI) to measure social relationships.
The scale range is 0-12.
The total score will be reported.
The maximum total score is 12. Higher values represent a broader diversity of social networks and are classified as a better outcome.
|
1-week Post-intervention
|
Patient Activation Measure
Time Frame: 1-week Post-intervention
|
Patient Activation Measure (PAM) Survey to measure self-reported active behavior in the self-management of chronic illness. The scale range is 0-100. The total score will be reported. The maximum total score is 100. Higher values represent high levels of activation in self-management. Higher values represent a better outcome. |
1-week Post-intervention
|
Patient Activation Measure
Time Frame: 3 months post-intervention
|
Patient Activation Measure (PAM) Survey to measure self-reported active behavior in the self-management of chronic illness. The scale range is 0-100. The total score will be reported. The maximum total score is 100. Higher values represent high levels of activation in self-management. Higher values represent a better outcome. |
3 months post-intervention
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Scale
Time Frame: 1-week Post-intervention
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Scale The scale range is 0-65. The total score will be reported. For each scale range provided, specify which values are considered to be a better or worse outcome (e.g., Do higher values represent a better or worse outcome?). The maximum total score is 65. Higher values represent higher levels of fatigue. |
1-week Post-intervention
|
Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Scale
Time Frame: 3 months post-intervention
|
The Measure includes a scale. Please provide the following scale information: Specify the full (unabbreviated) scale name and construct (i.e., indicate what the scale measures if not clear from name). Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Scale Include all scale ranges (i.e., minimum and maximum scores) required to interpret any values. For example, if the *total* score is reported, the *total* range should be provided. If *subscale* scores are reported, the range for each *subscale* should be provided. The scale range is 0-65. The total score will be reported. For each scale range provided, specify which values are considered to be a better or worse outcome (e.g., Do higher values represent a better or worse outcome?). The maximum total score is 65. Higher values represent higher levels of fatigue. If subscales are combined to compute a total score, consider indicating how subscales are combined (summed, averaged, etc.). N/A |
3 months post-intervention
|
Short Form-36 (SF-36)
Time Frame: 1-week Post-intervention
|
Short Form-36 (SF-36) or 36-Item Short Form Health Survey Instrument The SF-36 has eight scaled scores; the scores are weighted sums of the questions in each section. Scores range from 0 - 100. Lower scores = more disability, higher scores = less disability Sections: ∙ Vitality ∙ Physical functioning ∙ Bodily pain ∙ General health perceptions ∙ Physical role functi |
1-week Post-intervention
|
Short Form-36 (SF-36)
Time Frame: 3 months post-intervention
|
Short Form-36 (SF-36) or 36-Item Short Form Health Survey Instrument The SF-36 has eight scaled scores; the scores are weighted sums of the questions in each section. Scores range from 0 - 100. Lower scores = more disability, higher scores = less disability Sections: ∙ Vitality ∙ Physical functioning ∙ Bodily pain ∙ General health perceptions ∙ Physical role functi |
3 months post-intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Health services utilization
Time Frame: 1-week Post-intervention
|
Utilization of health services
|
1-week Post-intervention
|
Health services utilization
Time Frame: 3 months post intervention
|
Utilization of health services
|
3 months post intervention
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Infections
- Respiratory Tract Diseases
- Respiration Disorders
- Lung Diseases
- Systemic Inflammatory Response Syndrome
- Inflammation
- Disease Attributes
- Disease
- Infant, Newborn, Diseases
- Sepsis
- Lung Injury
- Infant, Premature, Diseases
- Syndrome
- Shock, Septic
- Respiratory Insufficiency
- Shock
- Chronic Disease
- Critical Illness
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Acute Lung Injury
- Hypovolemia
Other Study ID Numbers
- 2018-08-0097
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sepsis
-
University of Kansas Medical CenterUniversity of KansasRecruitingSepsis | Septic Shock | Sepsis Syndrome | Sepsis, Severe | Sepsis Bacterial | Sepsis BacteremiaUnited States
-
Jip GroenInBiomeRecruitingMicrobial Colonization | Neonatal Infection | Neonatal Sepsis, Early-Onset | Microbial Disease | Clinical Sepsis | Culture Negative Neonatal Sepsis | Neonatal Sepsis, Late-Onset | Culture Positive Neonatal SepsisNetherlands
-
Karolinska InstitutetÖrebro University, SwedenCompletedSepsis | Sepsis Syndrome | Sepsis, SevereSweden
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknown
-
Ohio State UniversityCompletedSepsis, Severe Sepsis and Septic ShockUnited States
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityRecruitingSevere Sepsis | Severe Sepsis Without Septic ShockUnited States
-
University of LeicesterUniversity Hospitals, Leicester; The Royal College of AnaesthetistsCompletedSepsis | Septic Shock | Severe Sepsis | Sepsis SyndromeUnited Kingdom
-
Zagazig UniversityRecruitingSepsis-associated EncephalopathyEgypt
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI); New York Presbyterian Hospital and other collaboratorsCompletedSepsis | Septic Shock | Severe Sepsis | Infection | Sepsis SyndromeUnited States
Clinical Trials on Peer Support with Motivational Interviewing
-
University of Illinois at Urbana-ChampaignUniversity of WashingtonNot yet recruiting
-
University of Illinois at Urbana-ChampaignUnknown
-
Qazvin University Of Medical SciencesCompletedObesity, AdolescentIran, Islamic Republic of
-
Northwestern UniversityCompletedDepressionUnited States
-
The Miriam HospitalLive Inspired, LLCCompletedSmoking CessationUnited States
-
Medical University of ViennaNational Bank of AustriaUnknownDiabetes Mellitus, Type 1Austria
-
Umeå UniversityUnknown
-
Boston CollegeNortheastern University; Brandeis UniversityCompletedPhysical Activity | Sedentary LifestyleUnited States
-
Universitätsklinikum Hamburg-EppendorfUniversity of UlmActive, not recruitingSevere Mental Health Condition With Indication of Hospital AdmissionGermany
-
VA Office of Research and DevelopmentCompletedPsychotic Disorders | Bipolar Disorder | UnemploymentUnited States